Aytu BioPharma, Inc. (AYTU) vs China Pharma Holdings, Inc. (CPHI)
- Aytu BioPharma, Inc. AYTU 2.04 +1.49%
- China Pharma Holdings, Inc. CPHI 0.71 −2.74%
Aytu BioPharma, Inc. and China Pharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. is the larger, with a market value of $31.3M against $21.8M — 1.4× the size. China Pharma Holdings, Inc. grew revenue faster over the last twelve months: −11.0% against −13.3%. Aytu BioPharma, Inc. has the higher net margin (−24.8% vs −114.3%) and the lower return on invested capital (−20.0% vs −7.23%). Across the 18 metrics below, Aytu BioPharma, Inc. leads on 11 and China Pharma Holdings, Inc. on 7.
Valuation
Profitability
| Metric | AYTU | CPHI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 63.95% | 11.76% | 53.94% |
| Operating margin | (14.44%) | (111.84%) | 0.00% |
| Net margin | (24.76%) | (114.33%) | 0.00% |
| Free cash flow margin | 5.62% | (3.59%) | 0.00% |
| Return on equity | (52.55%) | (20.99%) | (0.40%) |
| Return on assets | (12.44%) | (15.30%) | (3.32%) |
| Return on invested capital | (19.99%) | (7.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack